Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy

Particle and Fibre Toxicology

Volumn 2, Issue , 2005, Pages

  Oberdörster, Günter ^a   Maynard, Andrew ^b   Donaldson, Ken ^c   Castranova, Vincent ^d   Fitzpatrick, Julie ^e   Ausman, Kevin ^f   Carter, Janet ^g   Karn, Barbara ^b,h   Kreyling, Wolfgang ⁱ   Lai, David ^h   Olin, Stephen ^e   Monteiro Riviere, Nancy ^j   Warheit, David ^k   Yang, Hong ^l  

^a UNIVERSITY OF ROCHESTER   (United States)

^b WOODROW WILSON INTERNATIONAL CENTER FOR SCHOLARS   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^e International Life Sciences Institute   (United States)

^f RICE UNIVERSITY   (United States)

^g PROCTER AND GAMBLE COMPANY   (United States)

^h U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

ⁱ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^j NORTH CAROLINA STATE UNIVERSITY   (United States)

^k DUPONT COMPANY   (United States)

^l University of Rochester   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; COMPLEMENT; OXIDIZING AGENT;

BLOOD TOXICITY; CELL PROLIFERATION; CHEMICAL COMPOSITION; COMPLEMENT ACTIVATION; CRYSTAL STRUCTURE; DISEASE MARKER; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MODEL; FETOTOXICITY; HAZARD ASSESSMENT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFORMATION PROCESSING; LIVER TOXICITY; LUNG TOXICITY; MEDICAL EXPERT; MUCOSAL DISEASE; NANOPARTICLE; NANOTECHNOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICAL CHEMISTRY; POROSITY; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SKIN TOXICITY; SPLEEN DISEASE; SURFACE CHARGE; TOXICITY TESTING; TOXICOKINETICS;

ANIMALIA;

EID: 33845214358     PISSN: 17438977     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-8977-2-8     Document Type: Review

References (184)

1. Hood E: Nanotechnology: looking as we leap. Environ Health Perspect 2004, 112:A740-A749.
2. Bernstein D, Castranova V, Donaldson K, Fubini B, Hadley J, Hesterberg T, et al.: Testing of fibrous particles: short-term assays and strategies. Inhal Toxicol 2005, 17:497-537.
3. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ: Nanotoxicology. Occup Environ Med 2004, 61:727-728.
4. Goodman CM, McCusker CD, Yilmaz T, Rotello VM: Toxicity of gold nanoparticies functionalized with cationic and anionic side chains. Bioconjug Chem 2004, 15:897-900.
5. Cheng YS, Hansen GK, Su YF, Yeh HC, Morgan KT. Deposition of ultrafine aerosols in rat nasal molds. Toxicol Appl Pharmacol 1990, 106:222-233.
6. Kelly JT, Asgharian B: Nasal molds as predictors of fine and coarse particle deposition in rat nasal airways. Inhal Toxicol 2003, 15:859-875.
7. Baggs RB, Ferin J, Oberdorster G: Regression of pulmonary lesions produced by inhaled titanium dioxide in rats. Vet Pathol 1997, 34:592-597.
8. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, et al: Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 2004, 77:347-357.
9. Donaldson K, MacNee W: Potential mechanisms of adverse pulmonary and cardiovascular effects of particulate air pollution (PM10). Int J Hyg Environ Health 2001, 203:411-415.
10. Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, et al.: The pulmonary toxicology of ultrafine particles. J Aerosol Med 2002, 15:213-220.
11. Ferin J, Oberdorster G, Penney DP: Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol 1992, 6:535-542.
12. Ferin J: Pulmonary retention and clearance of particles. Toxicol Lett 1994, 72:121-125.
13. Kuschner WG, Wong H, D'Alessandro A, Quinlan P, Blanc PD: Human pulmonary responses to experimental inhalation of high concentration fine and ultrafine magnesium oxide particles. Environ Health Perspect 1997, 105:1234-1237.
14. Oberdorster G: Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001, 74:1-8.
15. Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
16. MacNee W, Donaldson K: How can ultrafine particles be responsible for increased mortality? Monaldi Arch Chest Dis 2000, 55:135-139.
17. Oberdorster G, Gelein RM, Ferin J, Weiss B: Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol 1995, 7:111-124.
18. Wichmann HE, Spix C, Tuch T, Wolke G, Peters A, Heinrich J, et al.: Daily mortality and fine and ultrafine particles in erfurt, germany part 1: role of particle number and particle mass. Res Rep Health Eff Inst 2000:5-86.
19. Zhu Y, Hinds WC, Krudysz M, Kuhn T, Froines J, Sioutas C: Penetration of freeway ultrafine particles into indoor environments. Journal of Aerosol Science 2005, 36:303-322.
20. Donaldson K, Gilmour MI, MacNee W: Asthma and PM10. Respir Res 2000, 1:12-15.
21. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J: Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 1997, 155:1376-1383.
22. Wong GW, Lai CK: Outdoor air pollution and asthma. Curr Opin Pulm Med 2004, 10:62-66.
23. Pekkanen J, Timonen KL, Ruuskanen J, Reponen A, Mirme A: Effects of ultrafine and fine particles in urban air on peak expiratory flow among children with asthmatic symptoms. Environ Res 1997, 74:24-33.
24. Penttinen P, Timonen KL, Tiittanen P, Mirme A. Ruuskanen J, Pekkanen J: Ultrafine particles in urban air and respiratory health among adult asthmatics. Eur Respir J 2001, 17:428-435.
25. Penttinen P, Timonen KL, Tiittanen P, Mirme A, Ruuskanen J, Pekkanen J: Number concentration and size of particles in urban air: effects on spirometric lung function in adult asthmatic subjects. Environ Health Perspect 2001, 109:319-323.
26. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR: Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 2004, 77:117-125.
27. Zhang Q, Kusaka Y, Zhu X, Sato K, Mo Y, Kluz T, et al.: Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health 2003, 45:23-30.
28. Heyder J, Takenaka S: Long-term canine exposure studies with ambient air pollutants. Eur Respir J 1996, 9:571-584.
29. Zhang Q, Kusaka Y, Sato K, Nakakuki K, Kohyama N, Donaldson K: Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: role of free radicals. J Toxicol Environ Health A 1998, 53:423-438.
30. Zhou YM, Zhong CY, Kennedy IM, Leppert VJ, Pinkerton KE: Oxidative stress and NFkappaB activation in the lungs of rats: a synergistic interaction between soot and iron particles. Toxicol Appl Pharmacol 2003, 190:157-169.
31. Barlow PG, Donaldson K, MacCallum J, Clouter A, Stone V: Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration. Toxicol Lett 2005, 155:397-401.
32. Brown DM, Donaldson K, Borm PJ, Schins RP, Dehnhardt M, Gilmour P, et al.: Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol 2004, 286:L344-L353.
33. Cui D, Tian F, Ozkan CS, Wang M, Gao H: Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 2005, 155:73-85.
34. Hetland RB, Cassee FR, Refsnes M, Schwarze PE, Lag M, Boere AJ, et al.: Release of inflammatory cytokines, cell toxicity and apoptosis in epithelial lung cells after exposure to ambient air particles of different size fractions. Toxicol In Vitro 2004, 18:203-212.
35. Ramage L, Guy K: Expression of C-reactive protein and heat-shock protein-70 in the lung epithelial cell line A549, in response to PM10 exposure. Inhal Toxicol 2004, 16:447-452.
36. Stearns RC, Paulauskis JD, Godleski JJ: Endocytosis of ultrafine particles by A549 cells. Am J Respir Cell Mol Biol 2001, 24:108-115.
37. Stone V, Tuinman M, Vamvakopoulos JE, Shaw J, Brown D, Petterson S, et al.: Increased calcium influx in a monocytic cell line on exposure to ultrafine carbon black. Eur Respir J 2000, 15:297-303.
38. Oberdorster G, Gelein RM, Ferin J, Weiss B: Association of particulate air pollution and acute mortality: involvement of ultrafine particles Inhal Toxicol 1995, 7:111-124.
39. Johnston CJ, Finkelstein JN, Gelein R, Baggs R, Oberdorster G: Characterization of the early pulmonary inflammatory response associated with PTFE fume exposure. Toxicol Appl Pharmacol 1996, 140:154-163.
40. Johnston CJ, Finkelstein JN, Mercer P, Corson N, Gelein R, Oberdorster G: Pulmonary effects induced by ultrafine PTFE particles. Toxicol Appl Pharmacol 2000, 168:208-215.
41. Srivastava R, McKinnon JT, Todd P: Particulates from PTFE degradation in terrestrial and microgravity. Aviat Space Environ Med 1999, 70:505-510.
42. Cassee FR, Muijser H, Duistermaat E, Freijer JJ, Geerse KB, Marijnissen JC, et al.: Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch Toxicol 2002, 76:277-286.
43. Oberdorster G: Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal Toxicol 1996, 8(Suppl):73-89.
44. Huang M, Khor E, Lim LY: Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 2004, 21:344-353.
45. Warheit DB: Nanoparticles: Health impacts? Materials Today 2004, 7:32-35.
46. Yang L, Watts DJ.: Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. Toxicology Letters 2005 in press. Corrected Proof.
47. Shvedova AA, Kisin ER, Mercer K, Murray AR, Johnson VJ, Potapovich AI, et al.: Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005.
48. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V: Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 2004, 67:87-107.
49. Larn CW, James JT, McCluskey R, Hunter RL: Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004, 77:126-134.
50. Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE: Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005, 155:377-384.
51. Monteiro-Riviere NA, Wang YY, Hong SM, Inman AO, Nernanich RJ, Tan J, et al.: Proteomic analysis of nanooparticle exposure in human keratonicyte cell culture. The Toxicologist 2005, 84:2183.
52. Cunningham MJ, Magnuson SR, Falduto MT: Gene expression profiling of nanoscale materials using a systems biology approach. The Toxicologist 2005, 84:9.
53. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, et al.: Respiratory toxicity of multi-wall carbon nanotubes. Toxicology and Applied Pharmacology in press. Corrected Proof.
54. Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, et al.: Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 2003, 66:1909-1926.
55. Oberdorster E: Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 2004, 112:1058-1062.
56. Lockman PR, Koziara JM, Mumper RJ, Allen DD: Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 2004, 12:635-641.
57. Yamakoshi Y, Sueyoshi S, Miyata N: [Biological activity of photoexcited fullerene]. Kokuritsu lyakuhin Shokuhin Eisei Kenkyusho Hokoku 1999:50-60.
58. Yamakoshi YN, Yagami T, Sueyoshi S, Miyata N: Acridine Adduct of [60]Fullerene with Enhanced DNA-Cleaving Activity. J Org Chem 1996, 61:7236-7237.
59. * versus IO2. J Am Chem Soc 2003, 125:12803-12809.
60. Avogbe PH, Yi-Fanou L, Autrup H, Loft S, Fayomi B, Sanni A, et al.: Ultrafine particulate matter and high-level benzene urban air pollution in relation to oxidative DNA damage. Carcinogenesis 2005, 26:613-620.
61. Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, et al.: Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 2005, 38:1080-1092.
62. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K: Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001, 175:191-199.
63. Derfus AM, Chan WCW, Bhatia SN: Probing the Cytotoxicity of Semiconductor Quantum Dots. Nano Letters 2004, 4:11-18.
64. Shiohara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K: On the cyto-toxicity caused by quantum dots. Microbiol Immunol 2004, 48:669-675.
65. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, et al.: Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 2003, 111:455-460.
66. Sayes CM, Gobin AM, Ausman KD, Mendez J, West JL, Colvin VL: Nano-C(60) cytotoxicity is due to lipid peroxidation. Biomaterials 2005, 26:7587-7595.
67. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D: Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 2005, 83:377-385.
68. Shiohara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K: On the cyto-toxicity caused by quantum dots. Microbiol Immunol 2004, 48:669-675.
69. Oberdorster G, Gelein RM, Ferin J, Weiss B: Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol 1995, 7:111-124.
70. Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
71. Oberdorster G: Toxicology of ultrafine particles: in vivo studies. Phil Trans Roy Soc London Series 2000, 358:2719-2740.
72. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR: Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 2004, 77:117-125.
73. Donaldson K, Stone V, Gilmour PS, Brown DM, MacNee W: Ultrafine particles: mechanisms of lung injury. Phil Trans Roy Soc London Series 2000, 358:2741-2749.
74. Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, et al.: Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 2003, 66:1909-1926.
75. Sayes C, Fortner J, Guo W, Lyon D, Boyd A, Ausman K, et al.: The Differential Cytotoxicity of Water-Soluble Fullerenes. American Chemical Society 2004, 4:1881-1887.
76. Searl A: A review of the durability of inhaled fibers and options for the design of safer fibers. Ann Occup Hyg 1994, 38:839-855.
77. Fubini B: Surface reactivity in the pathogenic response to particulates. Environ Health Perspect 1997, 105(Suppl 5):1013-1020.
78. Oberdorster G, Ferin J, Lehnert BE: Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 1994, 102(Suppl 5):173-179.
79. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, et al.: Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002, 65:1513-1530.
80. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdorster G, et al.: Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 2004, 16:453-459.
81. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, et al.: Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004, 16:437-445.
82. Jia G, Wang H, Yan L, Wang X, Pei R, Yan T, et al.: Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 2005, 39:1378-1383.
83. Araujo L, Lobenberg R, Kreuter J: Influence of the surfactant concentration on the body distribution of nanoparticles. J Drug Target 1999, 6:373-385.
84. Kirchner C, Liedl T, Kudera S, Pellegrino T, Munoz JA, Gaub HE, et al.: Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 2001, 5:331-338.
85. Baltensperger UE, Weingartner E, Burtscher H, Keskinen J: Dynamic Mass and Surface Area Measurement. In Aerosol Measurement Principles, Techniques, and Applications Edited by: Baron PA, Willeke K. New York: John Wiley and Sons; 2001:387-418.
86. Gebhart J: Optical Direct-Reading Techniques: Light Intensity Systems. In Aerosol Measurement Principles, Techniques, and Applications Edited by: Baron P, Willeke K. New York: John Wiley and Sons; 2001:419-454.
87. Ku BK, Maynard A: Comparing aerosol surface-area measurement of monodisperse ultrafine silver agglomerates using mobility analysis, transmission electron microscopy and diffusion charging. J Aerosol Sci 2005, 36:1108-1124.
88. Cheng Y-S: Condensation Detection and Diffusion Size Seperation Techniques. In Aerosol Measurement. Principles, Techniques and Applications Edited by: Baron P, Willeke K. New York: John Wiley and Sons; 2001:569-601.
89. Keller A, Fierz M, Siegmann K, Siegmann HC, Filippov A: A Surface Science with Nanosized Particles in Carrier Gas. J Vac Sci Technol A 2001, 19:1-8.
90. Flagan R: Electrical Techniques. In Aerosol Measurement: Principles, Techniques and Applications Edited by: Baron P, Willeke K. New York: John Wiley and Sons; 2001:537-568.
91. Fubini B, Aust AE, Bolton RE, Borm PJ, Brunch J, Ciapetto G, et al.: Non-animal tests for evaluating the toxicology of solid xenobiotics. Atla-Alternatives to Laboratory Animals 1998, 26:579-617.
92. Wilson WE, Han HS, Stanek J, Turner JH, Pui DYH: The fuchs surface area, as measured by charge acceprance of atmospheric particles, may be a useful indicator of the surface area of particles deposite in the lungs. Madrid Spain, Pergamon.
93. Brown DM, Stone V, Findlay P, MacNee W, Donaldson K: Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup Environ Med 2000, 57:685-691.
94. Kim H, Liu X, Kobayashi T, Kohyama T, Wen FQ, Romberger DJ, et al.: Ultrafine carbon black particles inhibit human lung fibroblast-mediated collagen gel contraction. Am J Respir Cell Mol Biol 2003, 28:111-121.
95. Gilmour PS, Rahman I, Donaldson K, MacNee W: Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. Am J Physiol Lung Cell Mol Physiol 2003, 284:L533-L540.
96. Schins RPF, Donaldson K: Nuclear factor kappa-B activation by particles and fibres. Inhal Toxicol 2000, 12:317-326.
97. Timblin CR, Guthrie GD, Janssen YW, Walsh ES, Vacek P, Mossman BT: Patterns of c-fos and c-jun proto-oncogene expression, apoptosis, and proliferation in rat pleural mesothelial cells exposed to erionite or asbestos fibers. Toxicol Appl Pharmacol 1998, 151:88-97.
98. Stringer B, Kobzik L: Environmental particulate-mediated cytokine production in lung epithelial cells (A549): role of preexisting inflammation and oxidant stress. Journal of Toxicology & Environmental Health 1998, 55:31-44.
99. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN: Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-alpha-induced oxidant stress. Am J Physiol 1999, 276:L979-L988.
100. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005, 6:150-166.
101. Janssen YM, Van Houten B, Borm PJ, Mossman BT: Cell and tissue responses to oxidative damage. Lab Invest 1993, 69:261-274.
102. Quinlan TR, BeruBe KA, Marsh JP, Janssen YW, Taishi P, Leslie KO, et al.: Patterns of inflammation, cell-proliferation, and related gene-expression in lung after inhalation of chrysotile asbestos. American Journal Of Pathology 1995, 147:728-739.
103. Schins RP: Mechanisms of genotoxicity of particles and fibers. Inhal Toxicol 2002, 14:57-78.
104. Schins RP, Knaapen AM, Cakmak GD, Shi T, Weishaupt C, Borm PJ: Oxidant-induced DNA damage by quartz in alveolar epithlial cells. Mutat Res 2002, 517:77-86.
105. Brown DM, Roberts NK, Donaldson K: Effect of coating with lung lining fluid on the ability of fibres to produce a respiratory burst in rat alveolar macrophages. Toxicology In Vitro 1998, ITRO:15-24.
106. Chao CC, Park SH, Aust AE: Participation of nitric-oxide and iron in the oxidation of dna in asbestos-treated human lung epithelial-cells. Archives Of Biochemistry And Biophysics 1996, 326:152-157.
107. Coffey MJ, Phare SM, Peters-Golden M: Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim Biophys Acta 2002, 1584:81-90.
108. Renwick LC, Donaldson K, Clouter A: Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 2001, 172:119-127.
109. Meiring A, Borm PJ, Bagate K, Semmler M, Seitz J, Takenaka S, et al.: The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol 2005, 2:3.
110. Monteiro-Riviere NA, Riviere JE: Skin Toxicology. In Toxicology Edited by: Marquardt H, Schafer S, McCellan R, Welsch F. San Diego: Academic Press; 1999:439-457.
111. Lansdown ABG, Taylor A: Zinc and titanium oxides: promising UV-absorbers but what influences do they have on the intact skin? Int J Cosmetic Science 1997, 19:167-172.
112. National Institute of Health: Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity 2001.
113. Qiao GL, Brooks JD, Riviere JE: Pentachlorophenoll dermal absorption and disposition from soil in swine: effects of occlusion and skin microorganism inhibition. Toxicol Appl Pharmacol 1997, 147:234-246.
114. Regnier M, Ortonne JP, Darmon M: Histological defects of chronic benign familial pemphigus expressed in tissue culture. Arch Dermatol Res 1990, 281:538-540.
115. Regnier M, Asselineau D, Lenoir MC: Human epidermis reconstructed on dermal substrates in vitro: an alternative to animals in skin pharmacology. Skin Pharmacol 1990, 3:70-85.
116. Monteiro-Riviere NA, Inman AO, Snider TH, Blank JA, Hobson DW: Comparison of an in vitro skin model to normal human skin for dermatological research. Microsc Res Tech 1997, 37:172-179.
117. Bronaugh RL, Stewart RF: Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. J Pharm Sci 1985, 74:64-67.
118. Chang SK, Riviere JE: Percutaneous absorption of parathion in vitro in porcine skin: effects of dose, temperature, humidity, and perfusate composition on absorptive flux. Fundam Appl Toxicol 1991, 17:494-504.
119. Riviere JE, Bowman KF, Monteiro-Riviere NA, Dix LP, Carver MP: The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundam Appl Toxicol 1986, 7:444-453.
120. Riviere JE, Monteiro-Riviere NA: The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. Crit Rev Toxicol 1991, 21:329-344.
121. Monteiro-Riviere NA: Specialized Technique: Isolated Perfused Porcine Skin Flap. In Methods for Skin Absorption Edited by: Kemppainen BW, Reifenrath WG. Boca Raton: CRC Press; 1990:175-189.
122. Jani PU, Florence AT, McCarthy DE: Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. International Journal of Pharmaceutics 1992, 84:245-252.
123. Jani PU, McCarthy DE, Florence AT: Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. International Journal of Pharmaceutics 1994, 105:157-168.
124. Powell JJ, Harvey RS, Ashwood P, Wolstencroft R, Gershwin ME, Thompson RP: Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun 2000, 14:99-105.
125. Moghimi SM, Hunter AC, Murray JC: Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
126. Zhou Y, Yokel RA: The Chemical Species of Aluminum Influences Its Paracellular Flux across and Uptake into Caco-2 Cells, a Model of Gastrointestinal Absorption. Toxicol Sci 2005, 87:15-26.
127. Kishikawa H, Miura S, Yoshida H, Hirokawa M, Nakamizo H, Higuchi H, et al.: Transmural pressure induces IL-6 secretion by intestinal epithelial cells. Clin Exp Immunol 2002, 129:86-91.
128. Quaroni A, Isselbacher KJ: Cytotoxic effects and metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in duodenal and ileal epithelial cell cultures. J Natl Cancer Inst 1981, 67:1353-1362.
129. Li M, Hurren R, Zastawny RL, Ling V, Buick RN: Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium. Br J Cancer 1999, 80:1123-1131.
130. Smith JM, Johanesen PA, Wendt MK, Binion DG, Dwinell MB: CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity. Am J Physiol Gastrointest Liver Physiol 2005, 288:G316-G326.
131. Urayama S, Musch MW, Retsky J, Madonna MB, Straus D, Chang EB: Dexamethasone protection of rat intestinal epithelial cells against oxidant injury is mediated by induction of heat shock protein. J Clin Invest 1998, 102:1860-1865.
132. Fichorova RN, Anderson DJ: Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999, 60:508-514.
133. Kubilus J, Cannon CL, Klausner M, Lonardo EC: Human tissue model for vaginal irritation studies. The Toxicologist 2002, 66:378.
134. Kubilus J, Breyfogle B, Sheasgreen J, Hayden P, Wertz P, Dale B, et al.: Characterization of New Buccal and Gingival Epithelial Tissue. MatTek Corporation web page 2004:1-2.
135. O'donnell VB: Free radicals and lipid signaling in endothelial cells. Antioxid Redox Signal 2003, 5:195-203.
136. Fleming J, Busse R: NO: the primary EDRF. J Mol Cell Cardiol 1999, 31:5-14.
137. Harrison DG, Treasure CB, Mugge A, Dellsperger KC, Lamping KG: Hypertension and the coronary circulation. With special attention to endothelial regulation. Am J Hypertens 1991, 4:454S-459S.
138. Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu H, et al.: Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 2002, 166:998-1004.
139. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al.: Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002, 65:1531-1543.
140. Worth AP, Balls M: Alternative (non-animal) methods for chemicals testing: current status and future prospects. 2002:71-82.
141. Dambach DM, Andrews BA, Moulin F: New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol Pathol 2005, 33:17-26.
142. Vickers AE, Rose K, Fisher R, Saulnier M, Sahota P, Bentley P: Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol 2004, 32:577-590.
143. Ricardo SD, Bertram JF, Ryan GB: Reactive oxygen species in puromycin aminonucleoside nephrosis: in vitro studies. Kidney Int 1994, 45:1057-1069.
144. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B: HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994, 45:48-57.
145. Raychowdhury MK, Ibarra C, Damiano A, Jackson GR Jr, Smith PR, McLaughlin M, et al.: Characterization of Na+-permeable cation channels in LLC-PKI renal epithelial cells. J Biol Chem 2004, 279:20137-20146.
146. Chou CC, Riviere JE, Monteiro-Riviere NA: The cytotoxicity of jet fuel aromatic hydrocarbons and dose-related interleukin-8 release from human epidermal keratinocytes. Arch Toxicol 2003, 77:384-391.
147. Rustom R, Wang B, McArdle F, Shalamanova L, Alexander J, McArdle A, et al.: Oxidative stress in a novel model of chronic acidosis in LLC-PKI cells. Nephron Exp Nephrol 2003, 95:e13-e23.
148. Panneerselvam K, Freeze HH: Mannose enters mammalian cells using a specific transporter that is insensitive to glucose. J Biol Chem 1996, 271:9417-9421.
149. Eastes W, Potter RM, Hadley JG: Estimation of dissolution rate from in vivo studies of synthetic vitreous fibers. Inhal Toxicol 2000, 12:1037-1054.
150. Warheit DB, George G, Hill LH, Snyderman R, Brody AR. Inhaled asbestos activates a complement-dependent chemoattractant for macrophages. Laboratory Investigation 1985, 52:505-514.
151. Barlow PG, Donaldson K, Maccallum J, Clouter A, Stone V: Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration. Toxicol Lett 2005, 155:397-401.
152. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K: Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001, 175:191-199.
153. Kim H, Liu X, Kobayashi T, Kohyama T, Wen FQ, Romberger DJ, et al.: Ultrafine carbon black particles inhibit human lung fibroblast-mediated collagen gel contraction. Am J Respir Cell Mol Biol 2003, 28:111-121.
154. McNeilly JD, Heal MR, Beverland IJ, Howe A, Gibson MD, Hibbs LR, et al.: Soluble transition metals cause the pro-inflammatory effects of welding fumes in vitro. Toxicol Appl Pharmacol 2004, 196:95-107.
155. Brown DM, Donaldson K, Borm PJ, Schins RP, Dehnhardt M, Gilmour P, et al.: Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol 2004, 286:L344-L353.
156. Marano F, Boland S, Bonvallot V, Baulig A, Baeza-Squiban A: Human airway epithelial cells in culture for studying the molecular mechanisms of the inflammatory response triggered by diesel exhaust particles. Cell Biol Toxicol 2002, 18:315-320.
157. Nel AE, Diaz-Sanchez D, Li N: The role of particulate pollutants in pulmonary inflammation and asthma: evidence for the involvement of organic chemicals and oxidative stress. Curr Opin Pulm Med 2001, 7:20-26.
158. Schins RP, Knaapen AM, Cakmak GD, Shi T, Weishaupt C, Borm PJ: Oxidant-induced DNA damage by quartz in alveolar epithelial cells. Mutat Res 2002, 517:77-86.
159. McNeilly JD, Heal MR, Beverland IJ, Howe A, Gibson MD, Hibbs LR, et al.: Soluble transition metals cause the pro-inflammatory effects of welding fumes in vitro. Toxicol Appl Pharmacol 2004, 196:95-107.
160. Wilson M, Lighthody JH, Donaldson K, Stone V: Oxidative Interactions between ultrafine particles and metals in vitro and in vivo. 2002.
161. Gilmour PS, Brown DM, Lindsay TG, Beswick PH, MacNee W, Donaldson K: Adverse health effects of PM10 particles: involvement of iron in generation of hydroxyl radical. Occupational & Environmental Medicine 1996, 53:817-822.
162. Schins RP, Knaapen AM, Cakmak GD, Shi T, Weishaupt C, Borm PJ: Oxidant-induced DNA damage by quartz in alveolar epithelial cells. Mutat Res 2002, 517:77-86.
163. Leanderson P, Soderkvist P, Tagesson C, Axelson O: Formation of DNA adduct 8-hydroxy-2′-deoxyguanosine induced by manmade mineral fibres. IARC Sci Publ 1988:422-424.
164. Driscoll KE, Howard BW, Carter JM, Janssen YM, Mossman BT, Isfort RJ: Mitochondrial-derived oxidants and quartz activation of chemokine gene expression. Adv Exp Med Biol 2001, 500:489-496.
165. Rao GV, Tinkle S, Weissman DN, Antonini JM, Kashon ML, Salmen R, et al.: Efficacy of a technique for exposing the mouse lung to particles
166. Oberdorster G: Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001, 74:1-8.
167. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K: Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. Inhal Toxicol 2000, 12:1113-1126.
168. Warheit DB, Carakostas MC, Hartsky MA, Hansen JF: Development of a short-term inhalation bioassay to assess pulmonary toxicity of inhaled particles: comparisons of pulmonary responses to carbonyl iron and silica. Toxicol Appl Pharmacol 1991, 107:350-368.
169. Warheit DB, Hansen JF, Yuen IS, Kelly DP, Snajdr SI, Hartsky MA: Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol Appl Pharmacol 1997, 145:10-22.
170. Fubini B, Hubbard A: Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 2003, 34:1507-1516.
171. Shi X, Ding M, Chen F, Wang L, Rojanasakul Y, Vallyathan V, et al.: Reactive oxygen species and molecular mechanism of silica-induced lung injury. J Environ Pathol Toxicol Oncol 2001, 20(Suppl 1):85-93.
172. Carter JM, Driscoll KE: The role of inflammation, oxidative stress, and proliferation in silica-induced lung disease: a species comparison. J Environ Pathol Toxicol Oncol 2001, 20(Suppl 1):33-43.
173. Fontanini G, Pingitore R, Bigini D, Vignati S, Pepe S, Ruggiero A, et al.: Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Am J Pathol 1992, 141:1285-1290.
174. Ettlin RA, Perentes E, Kolopp M, Lardelli P, Arnold J, Karamitopoulou E, et al.: Overview of quantitative methods in toxicologic pathology. In Vivo 1993, 7:315-324.
175. Kreyling W, Semmler M, Moller W: Health effects of ultrafine particles. Journal of Aerosol Science 2004, 35(Supplement 2):1155-1156. Ref Type: Journal (Full)
176. Asgharian B: Dosimetry software to predict particle deposition in humans and rats. 1999.
177. ICRP: Annals of the ICRP: Human Respiratory Tract Model for Radiological Protection. Pergamon. 1994.
178. Kreyling W, Scheuch G: Clearance of particles deposited in the lungs New York, Basel: Marcel Dekker Inc; 2000.
179. Rothen-Rutishauser BM, Kiama SG, Gehr P: A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 2005, 32:281-289.
180. Kiama SG, Cochand L, Karisson L, Nicod LP, Gehr P: Evaluation of phagocytic activity in human monocyte-derived dendritic cells. J Aerosol Med 2001, 14:289-299.
181. Kreyling WG, Blanchard JD, Godleski JJ, Haeussermann S, Heyder J, Hutzler P, et al.: Anatomic localization of 24- and 96-h particle retention in canine airways. J Appl Physiol 1999, 87:269-284.
182. Moller W, Barth W, Kohlhaufl M, Haussinger K, Stahlhofen W, Heyder J: Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in healthy and diseased subjects. Exp Lung Res 2001, 27:547-568.
183. U.S.Environmental Protection Agency: Health Effects Test Guidelines OPPTS 870.2500 Acute Dermal Irritation 1998.
184. U.S.Environmental Protection Agency: Health Effects Test Guidelines OPPTS 870.1200 Acute Dermal Toxicity 1998.